• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病治疗:全面综述所有疗法。

Treatment of Psoriasis: A Comprehensive Review of Entire Therapies.

机构信息

Chitkara College of Pharmacy, Chitkara University, Chandigarh-Patiala, NH 7, 64, Tehsil, Rajpura, Punjab, India.

NCRD's Sterling Institute of Pharmacy, Navi Mumbai, Maharastra, India.

出版信息

Curr Drug Saf. 2020;15(2):82-104. doi: 10.2174/1574886315666200128095958.

DOI:10.2174/1574886315666200128095958
PMID:31994468
Abstract

BACKGROUND

Psoriasis is an autoimmune disease that ingeminates itself with the repeated proliferation of keratinocytes. It globally strikes a 2-5 % population on an average. Management of psoriasis remains a daunting task with various challenges influencing treatment, such as patient conformity and adherence to therapy, delicate patient profiles, psychological aspects, and skin as a barrier to topical delivery. The first part reviewed pathophysiology, triggering factors, and clinical classification. The second part reviewed all the therapies, such as topical, oral, biological, parenteral therapy, phototherapy, and the phyto-pharmaceuticals.

METHODS

The research data related to the existing and upcoming therapies for psoriasis treatment, several nanocarriers, existing marketed formulations, and detailed description of phytopharmaceuticals with their mechanism.

RESULTS

Topical therapy is the mainstay treatment option with limited adverse effects. Biological therapy has reformed conventional psoriasis treatment by being more efficacious and has increased patient acceptance due to decreased adverse events. Nanoformulations present an edge over conventional therapy due to improved anti-psoriatic effect and decreased side effects. Phyto-pharmaceuticals act as a complementary and alternative therapy for diminishing psoriasis symptoms.

CONCLUSION

A rationalized cost-effective patient compliant therapy is required for effective management and complete cure of psoriasis.

摘要

背景

银屑病是一种自身免疫性疾病,其角质形成细胞会反复增殖。平均而言,全球有 2-5%的人口受到影响。由于各种因素影响治疗,如患者的依从性和对治疗的坚持、患者的特殊情况、心理方面以及皮肤作为局部递药的屏障等,银屑病的治疗仍然是一项艰巨的任务。第一部分回顾了银屑病的病理生理学、触发因素和临床分类。第二部分综述了所有的治疗方法,如局部治疗、口服治疗、生物治疗、注射治疗、光疗和植物药。

方法

本研究检索了与银屑病治疗的现有和新兴疗法、几种纳米载体、现有上市制剂以及植物药及其作用机制相关的数据。

结果

局部治疗是主要的治疗选择,不良反应有限。生物疗法通过更有效和减少不良反应来提高患者的接受度,从而改变了传统的银屑病治疗方法。纳米制剂由于改善了抗银屑病作用和减少了副作用,优于传统疗法。植物药作为一种补充和替代疗法,可减轻银屑病的症状。

结论

需要一种合理、经济、患者依从性好的治疗方法,以实现对银屑病的有效管理和完全治愈。

相似文献

1
Treatment of Psoriasis: A Comprehensive Review of Entire Therapies.银屑病治疗:全面综述所有疗法。
Curr Drug Saf. 2020;15(2):82-104. doi: 10.2174/1574886315666200128095958.
2
Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities.影响银屑病治疗依从性的因素:比较生物疗法与其他疗法。
J Dermatolog Treat. 2013 Feb;24(1):64-9. doi: 10.3109/09546634.2011.607425. Epub 2011 Sep 7.
3
Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.老年患者中轻度至中度银屑病的管理:局部治疗的作用
Drugs Aging. 2017 Aug;34(8):583-588. doi: 10.1007/s40266-017-0480-8.
4
Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.联合外用银屑病治疗以增强全身治疗和光疗:文献综述
J Drugs Dermatol. 2017 Dec 1;16(12):1209-1222.
5
Topical treatments for scalp psoriasis.头皮银屑病的局部治疗。
Drugs. 2008;68(16):2293-302. doi: 10.2165/0003495-200868160-00003.
6
Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.目前针对银屑病的治疗方法及未来展望——聚焦于血清素能药物。
Mol Neurobiol. 2020 May;57(5):2391-2419. doi: 10.1007/s12035-020-01889-3. Epub 2020 Feb 15.
7
Current challenges and emerging drug delivery strategies for the treatment of psoriasis.治疗银屑病的当前挑战与新兴药物递送策略
Expert Opin Drug Deliv. 2016 Oct;13(10):1461-73. doi: 10.1080/17425247.2016.1188801. Epub 2016 May 25.
8
Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.老年银屑病的实际管理:流行病学、临床方面、生活质量、患者教育及治疗选择
Drugs Aging. 2002;19(11):847-63. doi: 10.2165/00002512-200219110-00003.
9
Efficacy and safety of treatment modalities for psoriasis.银屑病治疗方式的疗效与安全性。
Cutis. 1998 Feb;61(2 Suppl):11-21.
10
Topical delivery for the treatment of psoriasis.局部递药治疗银屑病。
Expert Opin Drug Deliv. 2010 Aug;7(8):977-92. doi: 10.1517/17425247.2010.503953.

引用本文的文献

1
A Multimodal Approach to Managing Severe Psoriasis Vulgaris: A Case Report Leveraging Natural Therapies for Flare Control.一种治疗重度寻常型银屑病的多模式方法:利用自然疗法控制病情发作的病例报告
Life (Basel). 2025 Jul 25;15(8):1186. doi: 10.3390/life15081186.
2
Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like dermatitis by modulating ERK and NF-κB signaling pathways in mice.羟基酪醇通过调节小鼠的ERK和NF-κB信号通路改善咪喹莫特诱导的银屑病样皮炎。
Sci Rep. 2025 Aug 17;15(1):30125. doi: 10.1038/s41598-025-16198-9.
3
The Therapeutic Potential of for Psoriasis: A Combined Phytochemical, In Silico, and Experimental Approach.
[具体物质]对银屑病的治疗潜力:一种结合植物化学、计算机模拟和实验的方法。 (这里原文中“for Psoriasis”前面应该有具体物质未给出,所以翻译不太完整,可根据实际情况补充完整)
Int J Mol Sci. 2025 Jul 28;26(15):7290. doi: 10.3390/ijms26157290.
4
Balancing efficacy and hepatotoxicity: a comprehensive review of oral medications in psoriasis management.平衡疗效与肝毒性:银屑病治疗中口服药物的综合综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 25. doi: 10.1007/s00210-025-04334-1.
5
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease.新发触发因素背景下的红皮病型银屑病:度普利尤单抗相关及新冠病毒诱导的银屑病性疾病解析
Dermatopathology (Basel). 2025 Jun 9;12(2):17. doi: 10.3390/dermatopathology12020017.
6
Implementing Negative Control Outcomes to Assess Comparability of Treatments for Psoriasis and Psoriatic Arthritis.实施阴性对照结果以评估银屑病和银屑病关节炎治疗方法的可比性。
Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70156. doi: 10.1002/pds.70156.
7
Microbiome and Postbiotics in Skin Health.微生物群与后生元对皮肤健康的影响
Biomedicines. 2025 Mar 25;13(4):791. doi: 10.3390/biomedicines13040791.
8
Development and Evaluation of Hydrogel-Based Sulfasalazine-Loaded Nanosponges for Enhanced Topical Psoriasis Therapy.用于增强局部银屑病治疗的水凝胶基载柳氮磺胺吡啶纳米海绵的研制与评价
Pharmaceuticals (Basel). 2025 Mar 10;18(3):391. doi: 10.3390/ph18030391.
9
Pan-immune inflammation value and systemic inflammatory index as a measure of systemic inflammation in patients with psoriasis: A retrospective study.全免疫炎症值和全身炎症指数作为银屑病患者全身炎症的一种衡量指标:一项回顾性研究。
Medicine (Baltimore). 2025 Mar 7;104(10):e41715. doi: 10.1097/MD.0000000000041715.
10
Immunological profile of lactate metabolism-related genes in Psoriasis a comprehensive analysis based on bulk and single-cell RNA sequencing data.银屑病中乳酸代谢相关基因的免疫特征:基于批量和单细胞RNA测序数据的综合分析
Sci Rep. 2025 Feb 26;15(1):6872. doi: 10.1038/s41598-025-91237-z.